Abstract:Background: To quantitatively predict the probability of occult contralateral lymph node metastasis (cLNM) for pyriform sinus squamous cell carcinoma (PSSC) patients with ipsilateral node-positive necks to guide postoperative adjuvant treatment. Methods: Two hundred and twenty-seven PSSC patients with ipsilateral lymph node metastasis (iLNM) were retrospectively analyzed. Results: Multivariate logistic analyses showed that five factors including maximum tumor diameter (MTD) of more than 4.0 cm, existence of tumor extension across the midline (EAM), internal jugular vein adhesion (IJVA), lymphovascular invasion (LVI), and lymph nodal fusion ( LNF) were independent risk factors for cLNM. A predictive nomogram was created based on these factors. The accuracy and validity of our model were verified by concordance index (C-index) 0.862 [95% confidence interval (CI): 0.810-0.914] in development cohort and 0.860 (95% CI: 0.820-0.900) after 1,000 bootstrapping. The calibration curve also showed a relatively favorable agreement. We then stratified patients into three groups based on their cLNM risk scores. Possible cLNM rates for low-risk, moderate-risk, and relatively high-risk subgroups were 3.6%, 21.8%, and 60.7%, respectively. Conclusions: A new postoperative adjuvant radiotherapy (PART) strategy selection flow chart was created for PSSC patients based on our newly built nomogram which can effectively predict the individualized possibility of cLNM. For patients in high-risk subgroup, therapeutic-dose PART is highly recommended even for those with contralateral clinical N0 neck disease. For those in moderate-risk subgroup, prophylactic-dose PART is recommended. However, for patients in low-risk subgroup, regular follow-up is sufficient given the extremely low occult cLNM rate.

Preoperative SCC antigen, CRP serum levels, and lymph node density in oral squamous cell carcinoma

Prognostic roles of SCC antigen, CRP and CYFRA 21-1 in oral cavity squamous cell carcinoma

Pre-treatment levels of C-reactive protein and squamous cell carcinoma antigen for predicting the aggressiveness of pharyngolaryngeal carcinoma

Clinical significance of preoperative C-reactive protein and squamous cell carcinoma antigen levels in penile squamous cell carcinoma patients.

Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy

Clinical Effect of Postoperative Chemoradiotherapy in Resected Advanced Laryngeal Squamous Cell Carcinoma.

Development of a Novel Biomarker Model for Predicting Preoperative Lymph Node Metastatic Extent in Esophageal Squamous Cell Carcinoma1.

The Inflammatory Markers and Locoregional Pathological Results Both Have An Impact on the Prognosis of Oral Squamous Cell Carcinoma in Patients Who Have Undergone Neck Dissection

Analysis of prognostic factors through survival rate analysis of oral squamous cell carcinoma patients treated at the National Cancer Center: 20 years of experience

Comparison of the prognostic value of lymph node yield, lymph node ratio, and number of lymph node metastases in patients with oral squamous cell carcinoma

Prognostic value of lymph node involvement in oral squamous cell carcinoma

Prognostic Significance of Preoperative Lymph Node Assessment for Patients with Stage Pn0 Esophageal Squamous Cell Carcinoma after Esophagectomy.

Lymph node characteristics and their prognostic significance in oral squamous cell carcinoma

Association of the Number of Dissected Lymph Node (LN) with the Survivals of Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC) Patients Received Preoperative Chemoradiotherapy (CRT) Followed by Surgery.

Assessment and Treatment Strategies for Occult Contralateral Lymph Node Metastasis in Hypopharyngeal Squamous Cell Carcinoma Patients with Ipsilateral Node-Positive Necks

The Predictive Value of Serum Squamous Cell Carcinoma Antigen in Patients with Cervical Cancer Who Receive Neoadjuvant Chemotherapy Followed by Radical Surgery: a Single-Institute Study.

The number of pathologically positive lymph nodes and pathological tumor depth predicts prognosis in patients with poorly differentiated squamous cell carcinoma of the oral cavity

Outcome analysis of patients with well-differentiated oral cavity squamous cell carcinoma

Outcome analysis of patients with oral cavity cancer and extracapsular spread in neck lymph nodes

Comparative prognostic value of different preoperative complete blood count cell ratios in patients with oral cavity cancer treated with surgery and postoperative radiotherapy

Postoperative Serum Squamous Cell Carcinoma Antigen and Carcinoembryonic Antigen Predict Overall Survival in Surgical Patients with Esophageal Squamous Cell Carcinoma